Effects of ticagrelor vs clopidogrel on plasma adenosine concentrations in patients with an acute coronary syndrome

Trial Profile

Effects of ticagrelor vs clopidogrel on plasma adenosine concentrations in patients with an acute coronary syndrome

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Sep 2014

At a glance

  • Drugs Ticagrelor (Primary) ; Clopidogrel
  • Indications Acute coronary syndromes
  • Focus Pharmacodynamics
  • Sponsors AstraZeneca
  • Most Recent Events

    • 31 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top